Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy Srinivas

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Journal of Patient-Reported Outcomes|September 15, 2021
Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancerOlga Generalova, Mohana Roy, Evan Hall, et al.
The Oncologist|August 6, 2021
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic DiseaseRisa L Wong, Lorin A Ferris, Olivia A Do, et al.
The Lancet. Oncology|February 16, 2015
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based studyJenny J Ko, Wanling Xie, Nils Kroeger, et al.
The Journal of Urology|June 20, 2020
Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 InhibitorsGuru Sonpavde, Juliane Manitz, Chen Gao, et al.
European Urology|June 20, 2016
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumJ Connor Wells, Igor Stukalin, Craig Norton, et al.
Clinical Genitourinary Cancer|December 3, 2014
Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumChristos E Kyriakopoulos, Namita Chittoria, Toni K Choueiri, et al.
European Urology|June 17, 2014
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumDaniel Y C Heng, J Connor Wells, Brian I Rini, et al.
European Urology|August 7, 2013
Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapyNils Kroeger, Toni K Choueiri, Jae-Lyn Lee, et al.
Cancer|May 23, 2013
Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteriaNils Kroeger, Wanling Xie, Jae-Lyn Lee, et al.
European Urology|November 5, 2013
The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database ConsortiumFabio A B Schutz, Wanling Xie, Frede Donskov, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Journal of Patient-Reported Outcomes|September 15, 2021
Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancerOlga Generalova, Mohana Roy, Evan Hall, et al.
The Oncologist|August 6, 2021
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic DiseaseRisa L Wong, Lorin A Ferris, Olivia A Do, et al.
The Lancet. Oncology|February 16, 2015
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based studyJenny J Ko, Wanling Xie, Nils Kroeger, et al.
The Journal of Urology|June 20, 2020
Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 InhibitorsGuru Sonpavde, Juliane Manitz, Chen Gao, et al.
European Urology|June 20, 2016
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumJ Connor Wells, Igor Stukalin, Craig Norton, et al.
Clinical Genitourinary Cancer|December 3, 2014
Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumChristos E Kyriakopoulos, Namita Chittoria, Toni K Choueiri, et al.
European Urology|June 17, 2014
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumDaniel Y C Heng, J Connor Wells, Brian I Rini, et al.
European Urology|August 7, 2013
Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapyNils Kroeger, Toni K Choueiri, Jae-Lyn Lee, et al.
Cancer|May 23, 2013
Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteriaNils Kroeger, Wanling Xie, Jae-Lyn Lee, et al.
European Urology|November 5, 2013
The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database ConsortiumFabio A B Schutz, Wanling Xie, Frede Donskov, et al.
Pageof 16